Clinical Autonomic Research

, Volume 1, Issue 2, pp 167–172

The biochemical assessment of sympathoadrenal activity in man

  • Niels Juel Christensen
Review Paper


Sympathoadrenal activity in man can be assessed by measuring catecholamines in plasma or by recording impulses in sympathetic nerves to skin and muscles by microneurography. Several studies have indicated that forearm venous plasma noradrenaline concentration and muscle sympathetic nerve activity are closely correlated in normal subjects at rest as well as during various conditions with increased or decreased sympathetic activity. Both parameters are influenced by baroreceptors and increase with age. Plasma adrenaline should preferably be measured in arterial blood because the extraction of adrenaline in organs and tissues may increase considerably when plasma adrenaline increases. The problem of studying the metabolic clearance rate of noradrenaline but not of adrenaline is discussed. It is emphasized that sympathetic activity is highly differentiated and it should therefore be measured in specific organs and tissues. Sympathetic activity in internal organs can be studied by measuring the release of noradrenaline from these organs. Imaging technique may, however, prove useful in future studies. The significance of microdialysis, measurements of plasma catecholamine metabolites, dopa and dopamine, plasma neuropeptide Y, catecholamines in urine and in the cerebrospinal fluid is discussed. Furthermore, it is emphasized that adrenergic agonist and antagonist drugs are important tools to study sensitivity and responsiveness to catecholamines preferably in specific organs and tissues. Finally, a few examples are given of the values in human research of the techniques described.

Key words

Adrenaline Clearance Dopa Imaging Microdialysis Microneurography Neuropeptide Y Noradrenaline Sympathetic 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cryer PE (ed.). Workshop on catecholamines and metabolism.Am J Pbysiol 1984;247: El–E74 and E137–E220.Google Scholar
  2. 2.
    Hjemdahl P (ed.). Plasma catecholamines as markers for sympatho-adrenal activity in man: a workshop.Acta Physiol Stand 1984;527 (suppl.): 1–54.Google Scholar
  3. 3.
    Christensen NJ, Henriksen O, Lassen NA (eds).Tbe Sympatboadrenal System. Physiology and palbopbysiology. New York: Raven Press, 1986; 1–512.Google Scholar
  4. 4.
    Steptoe A. The assessment of sympathetic nervous function in human stress research.J Psycbosom Res 1987;31: 141–152.Google Scholar
  5. 5.
    Eckberg DL, Rea RF, Andersson OK, Hedner T, Pernow J, Lundberg JM, Wallin BG. Baroflex modulation of sympathetic activity and sympathetic neurotransmitters in humans.Acta Pbysiol Scand 1988;133: 221–231.Google Scholar
  6. 6.
    Wallin BG, Sundlöf G, Eriksson BM, Dominiak P, Grobecker H, Lindblad LE. Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man.Acta Physiol Scand 1981;111: 69–73.PubMedGoogle Scholar
  7. 7.
    Hjemdahl P, Fagius J, Freyschuss U, Wallin BG, Daleskog M, Bohlin G, Perski A. Muscle sympathetic activity and norepinephrine release during mental challenge in humans.Am J Pbysiol 1989;287: E654-E664.Google Scholar
  8. 8.
    Fagius J, Niklasson F, Berne C. Sympathetic outflow in human muscle nerves increases during hypoglycemia.Diabetes 1986;35: 1124–1129.PubMedGoogle Scholar
  9. 9.
    Astrup A, Bülow J, Christensen NJ, Madsen J, Quaade F. Facultative thermogenesis induced by carbohydrate: a skeletal muscle component mediated by epinephrine.Am J Pbysiol 1986;250: E226-E229.Google Scholar
  10. 10.
    Best JD, Halter JB. Release and clearance rates of epinephrine in man: importance of arterial measurements.J Clin Endocrinol Metab 1982;55: 263–268.PubMedGoogle Scholar
  11. 11.
    Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W, Lambert G. Assessment of human sympathetic nervous system activity from measurements of norepinephrine.Hypertension 1988;11: 3–20.Google Scholar
  12. 12.
    Christensen NJ, Henriksen JH. Total norepinephrine spillover.Hypertension 1988;12: 468–469.PubMedGoogle Scholar
  13. 13.
    Henriksen JH, Christensen NJ. Plasma norepinephrine in humans: limitations in assessment of whole body norepinephrine kinetics and plasma clearance.Am J Pbysiol 1989;257: E743-E750.Google Scholar
  14. 14.
    Christensen NJ, Henriksen JH. Degradation of endogenous catecholamines. In: Henriksen JH, ed.Degradation of Bioactive Substances. Pbysiology and patbopbjsiology. Boca Raton, Florida: CRC Press, 1991; 289–305.Google Scholar
  15. 15.
    Gotdstein DS, Chang PC, Eisenhofer G, Miletich R, Finn R, Bacher J, Kirk KL, Bacharach S, Kopin IJ. Positron emission tomographic imaging of cardiac sympathetic innervation and function.Circ 1990;81: 1606–1621.Google Scholar
  16. 16.
    Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin IJ. Plasma dihydroxyphenylglykol and the intraneuronal disposition of norepinephrine in humans.J Clin Invest 1988;81: 213–220.PubMedGoogle Scholar
  17. 17.
    Ludwig J, Gerhardt T, Halbrügge T, Walter J, Graefe K-H. Plasma concentration of noradrenaline and 3,4-dihydroxyphenylethyleneglykol under conditions of enhanced sympathetic activity.Eur J Clin Invest 1988;38: 261–267.Google Scholar
  18. 18.
    Christensen NJ, Dejgård A, Hilsted J. Plasma dihydroxyphenylglykol (DHPG) as an index of diabetic autonomic neuropathy.Clin Pbysiol 1988;8: 577–580.Google Scholar
  19. 19.
    Lund M, Eldrup E, Bratholm P, Christensen NJ. The relationship between age and plasma concentrations of norepinephrine, catecholamine metabolites, DOPA and neuropeptide Y in normal human subjects.Scand J Clin Lab Invest (in press) 1991.Google Scholar
  20. 20.
    Kopin IJ. Catecholamine metabolism: basic aspects and clinical significance.Pharmacol Rev 1985;37: 333–364.PubMedGoogle Scholar
  21. 21.
    Eldrup E, Christensen NJ, Andreasen J, Hilsted J. Plasma dihydroxyphenylalanine (DOPA) is independent of sympathetic activity in humans.Eur J Clin Invest 1989;19: 514–517.PubMedGoogle Scholar
  22. 22.
    Goldstein DS, Udelsman R, Eisenhofer G, Stull R, Keiser HR, Kopin U, Folio CJ. Neuronal source of plasma dihydroxyphenylalanine.J Clin Endocrinol Metab 1987;64: 856–861.PubMedGoogle Scholar
  23. 23.
    Ziegler MG, Lake CR, Wood JH, Brooks BR, Ebert MH. Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood-cerebrospinal fluid barrier for norepinephrine.J Neurocbem 1977;28: 677–679.Google Scholar
  24. 24.
    Vlachakis ND, Lampano C, Alexander N, Maronde RF. Catecholamines and their major metabolites in plasma and cerebrospinal fluid of man.Brain Res 1981;229: 67–74.PubMedGoogle Scholar
  25. 25.
    Pemow J, Lundberg JM, Kaijser L, Hjemdahl P, Theodorsson-Norheim E, Martinsson A, Pernow B. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.Clin Pbysiol 1986;6: 561–578.Google Scholar
  26. 26.
    Rector TS, Olivari MT, Levine TB, Francis GS, Cohn JN. Predicting survival for an individual with congestive heart faiture using the plasma norepinephrine concentration.Am Heart J 1987;114: 148–182.PubMedGoogle Scholar
  27. 27.
    Tage-Jensen U, Henriksen JH, Christensen E, Widding A, Ring-Larsen H, Christensen NJ. Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis.J Hepatology 1988;6: 350–358.Google Scholar
  28. 28.
    Mathias CJ. Effect of food intake on cardiovascular control in patients with impaired autonomic function.J Neurosci Metbods 1990;34: 193–200.Google Scholar
  29. 29.
    Brown MJ, Jenner DA, Allison DJ, Dollery CT. Variations in individual organ release of noradrenaline measured by an improved radioenzymatic technique; limitations of peripheral venous measurements in the assessment of sympathetic nervous activity.Clin Sci 1981;61: 585–590.PubMedGoogle Scholar
  30. 30.
    Henriksen JH, Christensen NJ, Ring-Larsen H. Continuous infusion of tracer norepinephrine may miscalculate unidirectional nerve uptake of norepinephrine in humans.Circ Res 1989;65: 388–395.PubMedGoogle Scholar
  31. 31.
    Savard GK, Richter EA, Strange S, Kiens B, Christensen NJ, Saltin B. Norepinephrine spillover from skeletal muscle during exercise in humans: role of muscle mass.Am J Pbysiol 1989;257: H1812-H1818.Google Scholar
  32. 32.
    Mathias CJ, Bannister RB, Cortelli P, Heslop K, Polak JM, Raimbach S, Springall DR, Watson L. Clinical, autonomic and therapeutic observations in two siblings with postural hypotension and sympathetic failure due to an inability to synthesize noradrenaline from dopamine because of a deficiency of dopamine beta hydroxylase.Q J Med 1990;75: 617–633.PubMedGoogle Scholar

Copyright information

© Rapid Communications of Oxford Ltd. 1991

Authors and Affiliations

  • Niels Juel Christensen
    • 1
  1. 1.Department of Internal Medicine and EndocrinologyHerlev University HospitalHerlevDenmark

Personalised recommendations